Plain-English translation of NCT05877755 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing a new type of heart imaging technology that is faster, simpler, and more automated than current methods. The goal is to make high-quality heart imaging available to more patients by reducing the time needed, the complexity of the scan, and the need for specialized expertise. This new imaging approach could help doctors diagnose heart disease, assess risk, and choose the best treatment for each patient.
Heart disease is the leading cause of death in Europe, but current heart imaging scans are slow, complicated, and require highly trained specialists. This trial exists to make this life-saving imaging technology faster and easier so that more patients can benefit from it.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would come to the hospital for a cardiac MRI scan using the new imaging technology. The scan happens in a single continuous session where you breathe normally — you don't need to hold your breath. The entire process is designed to be faster and simpler than traditional heart imaging, with the results automatically analyzed by the new system.
AI-generated summary from trial data · Aug 30, 2026 · Not medical advice
France
University Hospital, Bordeaux
Collaborators
Grant Agreement ERC SMHEART
Enrollment target
~200 participants
Started
April 2025
Primary completion
March 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
BUSTIN Aurelien, PHD
University Hospital, Bordeaux
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.